Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Use and Impact of a Molecular Identification Assay in the Diagnosis and Management of Bloodstream Infections at in Healthcare Settings in Princess Marina Hospital, Botswana

NCT03255759 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.

NCT NCT03255759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03255759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Use and Impact of a Molecular Identification Assay in the Diagnosis and Management of Bloodstream Infections at in Healthcare Settings in Princess Marina Hospital, Botswana
Lead sponsor
Foundation for Innovative New Diagnostics, Switzerland
Phase
Not applicable
Overall status
Completed
Start date
May 24, 2018
Completion date
March 31, 2020
Enrollment
312 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection